ANI Pharmaceuticals Inc (ANIP)

Exchange
NASDAQ
Symbol
ANIP
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets brand-name and generic prescription pharmaceuticals in the United States and Canada. The company is headquartered in Baudette, Minnesota.
Country
USA

Stock price

At close: November 5, 2024

  • Open
    55.60
  • High
    57.68
  • Low
    55.55
  • Close
    57.31
  • Volume
    165,258

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
3.62
Receivables turnover
2.80
Payables turnover
10.99
Working capital turnover
1.21
Days of inventory on hand (DOH)
100.71
Days of sales outstanding (DSO)
130.21
Number of days of payables
33.22
Fixed asset turnover
10.19
Total asset turnover
0.50
 Liquidity ratios
Current ratio
3.57
Quick ratio
2.63
Cash ratio
1.52
Cash conversion cycle
197.70
 Solvency ratios
Debt-to-assets ratio
0.31
Debt-to-capital ratio
0.40
Debt-to-equity ratio
0.66
Financial leverage ratio
2.09
Interest coverage
1.45
 Profitability ratios
Gross profit margin
11.30%
Operating profit margin
10.34%
Pretax margin
4.37%
Net profit margin
4.13%
Operating return on assets (Operating ROA)
5.19%
Return on assets (ROA)
2.08%
Return on total capital
6.55%
Return on equity (ROE)
4.34%